Sarepta Therapeutics (SRPT) PT Lowered to $203 at Barclays

August 8, 2024 5:12 AM EDT Send to a Friend

Barclays analyst Gena Wang lowered ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Sarepta Therapeutics (SRPT) PT Lowered to $203 at Barclays

Member Login

Free News Feed